Extensive renal sinus lipomatosis in xanthogranulomatous pyelonephritis simulating liposarcoma

ABSTRACT

Renal replacement lipomatosis is a condition characterized by varying degrees of renal parenchymal atrophy and perirenal fibrofatty proliferation secondary to chronic inflammation such as xanthogranulomatous pyelonephritis. In severe cases, imaging findings can be misdiagnosed as retroperitoneal liposarcoma.

CASE PRESENTATION

A 63-year-old man was admitted to the hospital with generalized weakness, fever and weight loss for 6 months. Blood tests showed a creatinine level of 5.29mg/dl, an urea of 169mg/dl, a C-reactive protein of 297.7mg/L and urinalysis with leukocyturia.

Plain abdominal radiograph demonstrated right renal staghorn calculi (Figure-1). Computed tomography (CT) images showed obstructive stone, dilated calyces and renal parenchymal atrophy with exuberant fibrofatty proliferation (Figures 2 and 3). Final diagnosis was xanthogranulomatous pyelonephritis with extensive lipomatosis.

Figure 1
Abdominal radiography demonstrates staghorn calculus in right kidney.

Figure 2
Axial post-contrast CT images show obstructive stones, dilated calyces and renal parenchymal atrophy on the right kidney. Exuberant fibrofatty proliferation in renal sinus, indicating renal replacement lipomatosis (A, B and C). calyceal dilatation with a multiloculated aspect similar to the toe pads of a bear's paw in XGP (D).

Figure 3
Sagittal and coronal CT images show calculi, dilated calyces and renal parenchymal atrophy and exuberant fibrofatty proliferation.

DISCUSSION

Renal chronic inflammation from several etiologies may induce renal parenchymal atrophy and proliferation of inflammatory and fatty cells. In severe cases of fatty proliferation and renal atrophy, the term renal replacement lipomatosis (RRL) can be used (¹–⁴).

Xanthogranulomatous pyelonephritis (XGP) is a form of chronic inflammation, characterized by an obstructive staghorn calculous, hydronephrosis and renal atrophy (¹–⁴). On pathology, there is destruction of renal parenchyma and replacement by lipid-laden macrophages (xanthoma cells) associated to other inflammatory cells, including plasma cells, leukocytes, and histiocytes (¹–⁴).

Typical symptoms are nonspecific, such as flank pain, fever, fatigue, weight loss and dysuria. A palpable flank mass may be detected on physical examination. Leukocytosis and anemia are common laboratory findings and urine culture may identify Escherichia coli, Proteus mirabilis, Staphylococcus aureus, Klebsiella or Pseudomonas (⁴–⁶).

Plain radiography may demonstrate a large staghorn calculus, renal contour enlargement and, in advanced disease, obscuration of ipsilateral psoas margin (¹, ⁵). Ultrasound usually depicts renal enlargement with dilated calyces and parenchymal destruction, renal stone and staghorn calculus (¹, ⁴). In RRL, lipomatous tissue from renal sinus appear as an hyperechoic mass, indistinguishable from a primary retroperitoneal mesenchymal tumor (⁵).

Despite the findings on plain radiography and ultrasound, CT remains the best imaging modality to evaluate these conditions, not only for diagnosis but also to evaluate extension and surgical planning. An obstructive pelvic stone and calyceal dilatation with a multiloculated aspect can be observed, similar to the toe pads of a bear's paw in XGP. This appearance reflects an atrophic renal parenchyma replaced by enlarged calyces with thick content (², ⁴, ⁶–⁸).

In the RRL, besides the findings of XGP, there is extensive fatty tissue within the renal sinus, hilum and perinephric space (², ⁵). Those characteristics are shared with retroperitoneal liposarcoma, a rare tumor that arises from the re-troperitoneum that may occur in this region, and may impose diagnostic dilemmas (⁹). Since in RRL and XGP there is minimal or absent renal function on the affected kidney, nephrectomy is usually the treatment of choice (¹⁰).

• Published as Ahead of Print: February 28, 2018

REFERENCES

• ¹
  Craig WD, Wagner BJ, Travis MD. Pyelonephritis: radiologic-pathologic review. Radiographics. 2008;28:255-77; quiz 327-8.
• ²
  Sakata Y, Kinoshita N, Kato H, Yamada Y, Sugimura Y. Coexistence of renal replacement lipomatosis with xanthogranulomatous pyelonephritis. Int J Urol. 2004;11:44-6.
• ³
  Fitzgerald E, Melamed J, Taneja SS, Rosenkrantz AB. MRI appearance of massive renal replacement lipomatosis in the absence of renal calculus disease. Br J Radiol. 2011;84:e41-4.
• ⁴
  Kim J. Ultrasonographic features of focal xanthogranulomatous pyelonephritis. J Ultrasound Med. 2004;23:409-16.
• ⁵
  Karasick S, Wechsler RJ. Case 23: replacement lipomatosis of the kidney. Radiology. 2000;215:754-6.
• ⁶
  Fan CM, Whitman GJ, Chew FS. Xanthogranulomatous pyelonephritis. AJR Am J Roentgenol. 1995;165:1008.
• ⁷
  Tan WP, Papagiannopoulos D, Elterman L. Bear's Paw Sign: A Classic Presentation of Xanthogranulomatous Pyelonephritis. Urology. 2015;86:e5-6.
• ⁸
  Dyer RB, Chen MY, Zagoria RJ. Classic signs in uroradiology. Radiographics. 2004;24 Suppl 1:S247-80.
• ⁹
  Shaaban AM, Rezvani M, Tubay M, Elsayes KM, Woodward PJ, Menias CO. Fat-containing Retroperitoneal Lesions: Imaging Characteristics, Localization, and Differential Diagnosis. Radiographics. 2016;36:710-34.
• ¹⁰
  Khan M, Nazir SS, Ahangar S, Farooq Qadri SJ, Salroo NA. Total renal replacement lipomatosis. Int J Surg. 2010;8:263-5.

Publication Dates

• Publication in this collection
  May-Jun 2018

History

• Received
  30 Sept 2017
• Accepted
  29 Dec 2017